Table 1.
Baseline patient characteristics between pediatric and adult groups
| Baseline characteristics | Total patients (%) | Adult group (n=18), n (%) | Pediatric group (n=7), n (%) | P |
|---|---|---|---|---|
| Age (years) | 33.92±19.63 | 44±12.44 | 8±3.87 | |
| 42 (2-66) | 47 (18-66) | 8 (2-13) | ||
| Male: female | 6 (24):19 (76) | 4 (22.2):14 (77.8) | 2 (28.6):5 (71.4) | 0.739 |
| Weight (kg) | 51.16±20.17 | 61.72±10.2 | 24±11.72 | |
| 56 (11-80) | 61.5 (40-80) | 22 (11-46) | ||
| Body surface area (m2) | 1.43±0.4 | 1.64±0.14 | 0.8±0.2 | |
| 1.6 (0.51-1.88) | 1.62 (1.33-1.88) | 0.87 (0.5-1.3) | ||
| Symptoms | ||||
| Asymptomatic | 5 | 1 (5.9) | 4 (80) | 0.01 |
| Dyspnea NYHA class II | 17 | 16 (94.1) | 1 (20) | <0.001 |
| Palpitation | 5 | 5 (29.4) | 0 | 0.168 |
| Growth delay | 1 | 0 | 1 (20) | 0.059 |
| Right heart failure | 1 | 1 (5.9) | 0 | 0.579 |
| Comorbidities | ||||
| Systemic hypertension | 2 | 2 (11.8) | 0 | 0.421 |
| Atrial fibrillation | 1 | 1 (5.9) | 0 | 0.524 |
| Pulmonary thromboembolism | 1 | 1 (5.9) | 0 | |
| Valvular PS + RPA stenosis | 1 | 1 (5.9) | 0 | |
| Pre procedural TEE | 13 (59.1) | 13 (76.5) | 0 | 0.002 |
| Number of defects | ||||
| Two | 19 (76) | 14 (77.8) | 5 (71.4) | 0.414 |
| Three | 2 (8) | 2 (11.1) | 0 | |
| Multifenestrated | 4 (16) | 2 (11.1) | 2 (28.6) | |
| Defect size-echo (mm) | ||||
| Smaller defect size | 12.52±4.27 | 13.44±4.37 | 9.6±2.41 | 0.067 |
| 11 (7-20) | 11.5 (8-20) | 9 (7-13) | ||
| Larger defect size | 18.67±5.7 | 19.88±5.81 | 14.8±3.35 | 0.057 |
| 18 (10-32) | 19.5 (11-32) | 14 (10-18) | ||
| Pulmonary hypertension | ||||
| No | 6 (24) | 3 (16.7) | 3 (42.9) | 0.390 |
| Mild | 15 (60) | 11 (61.1) | 4 (57.1) | |
| Moderate | 3 (12) | 3 (16.7) | 0 | |
| Severe | 1 (4) | 1 (5.6) | 0 |
TEE: Transesophageal echocardiography; NYHA: New York heart association; PS: Pulmonary stenosis; RPA: Right pulmonary artery; LPA: Left pulmonary artery